Works matching IS 00099236 AND DT 2006 AND VI 80 AND IP 5
Results: 19
ABCB1 gene polymorphisms are not associated with treatment outcome in elderly acute myeloid leukemia patients<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2006, v. 80, n. 5, p. 427, doi. 10.1016/j.clpt.2006.07.005
- By:
- Publication type:
- Article
Transcriptional profiling of genes induced in the livers of patients treated with carbamazepine<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2006, v. 80, n. 5, p. 440, doi. 10.1016/j.clpt.2006.08.013
- By:
- Publication type:
- Article
CYP2A6 genotype and the metabolism and disposition kinetics of nicotine<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2006, v. 80, n. 5, p. 457, doi. 10.1016/j.clpt.2006.08.011
- By:
- Publication type:
- Article
High-dose methotrexate in pediatric acute lymphoblastic leukemia: Impact of ABCC2 polymorphisms on plasma concentrations<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2006, v. 80, n. 5, p. 468, doi. 10.1016/j.clpt.2006.08.012
- By:
- Publication type:
- Article
Disposition and sterol-lowering effect of ezetimibe are influenced by single-dose coadministration of rifampin, an inhibitor of multidrug transport proteins<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2006, v. 80, n. 5, p. 477, doi. 10.1016/j.clpt.2006.07.006
- By:
- Publication type:
- Article
Impact of P-glycoprotein on clopidogrel absorption.
- Published in:
- Clinical Pharmacology & Therapeutics, 2006, v. 80, n. 5, p. 486, doi. 10.1016/j.clpt.2006.07.007
- By:
- Publication type:
- Article
Voriconazole, but not terbinafine, markedly reduces alfentanil clearance and prolongs its half-life<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2006, v. 80, n. 5, p. 502, doi. 10.1016/j.clpt.2006.07.008
- By:
- Publication type:
- Article
Rifampin induces alterations in mycophenolic acid glucuronidation and elimination: Implications for drug exposure in renal allograft recipients.
- Published in:
- Clinical Pharmacology & Therapeutics, 2006, v. 80, n. 5, p. 509, doi. 10.1016/j.clpt.2006.08.002
- By:
- Publication type:
- Article
Effect of grapefruit juice on cytochrome P450 2A6 and nicotine renal clearance<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2006, v. 80, n. 5, p. 522, doi. 10.1016/j.clpt.2006.08.006
- By:
- Publication type:
- Article
Sex differences in CYP3A activity using intravenous and oral midazolam<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2006, v. 80, n. 5, p. 531, doi. 10.1016/j.clpt.2006.08.014
- By:
- Publication type:
- Article
Initial 48-hour acid inhibition by intravenous infusion of omeprazole, famotidine, or both in relation to cytochrome P450 2C19 genotype status<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2006, v. 80, n. 5, p. 539, doi. 10.1016/j.clpt.2006.08.010
- By:
- Publication type:
- Article
Impact of CYP2C9*3/*3 genotype on the pharmacokinetics and pharmacodynamics of piroxicam<sup>*</sup>.
- Published in:
- 2006
- By:
- Publication type:
- Letter
Tolerability of β-blockers metabolized via cytochrome P450 2D6 is sex-dependent<sup>*</sup>.
- Published in:
- 2006
- By:
- Publication type:
- Letter
Warfarin dose requirement for patients with both VKORC1 3673A/A and CYP2C9*3/*3 genotypes.
- Published in:
- 2006
- By:
- Publication type:
- Letter
The 2988G>A polymorphism affects splicing of a CYP2D6 minigene.
- Published in:
- 2006
- By:
- Publication type:
- Letter
Reply<sup>*</sup>.
- Published in:
- 2006
- By:
- Publication type:
- Letter
Correction.
- Published in:
- 2006
- Publication type:
- Correction Notice
Grant Robert Wilkinson, 1941–2006.
- Published in:
- 2006
- By:
- Publication type:
- Obituary
Possible role for human leukocyte antigen haplotype in rofecoxib-associated acute pancreatitis and cholestatic hepatitis.
- Published in:
- 2006
- By:
- Publication type:
- Letter